Stockreport

BRIEF-Lexicon Pharmaceuticals initiates patient dosing in a phase 1 study of LX9211 [Reuters]

Lexicon Pharmaceuticals, Inc.  (LXRX) 
Last lexicon pharmaceuticals, inc. earnings: 4/27 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: lexpharma.com/investors
PDF BRIEF-Lexicon Pharmaceuticals initiates patient dosing in a phase 1 study of LX9211 | Reuters Reuters Staff 1 Min Read Sept 27 (Reuters) - Lexicon Pharmaceuticals Inc * [Read more]